Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 94

1.

Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models.

Argenziano M, Gigliotti CL, Clemente N, Boggio E, Ferrara B, Trotta F, Pizzimenti S, Barrera G, Boldorini R, Bessone F, Dianzani U, Cavalli R, Dianzani C.

Cancers (Basel). 2020 Jan 9;12(1). pii: E162. doi: 10.3390/cancers12010162.

2.

Lipoprotein-Associated Phospholipase A2 Predicts Lower Limb Ischemia in Hemodialysis Subjects.

De Mauri A, Vidali M, Chiarinotti D, Dianzani U, Rolla R.

Ther Apher Dial. 2019 Dec 20. doi: 10.1111/1744-9987.13465. [Epub ahead of print]

PMID:
31863555
3.

ICOSLG-mediated regulatory T cell expansion and IL-10 production promote progression of glioblastoma.

Iwata R, Lee JH, Hayashi M, Dianzani U, Ofune K, Maruyama M, Oe S, Ito T, Hashiba T, Yoshimura K, Nonaka M, Nakano Y, Norian L, Nakano I, Asai A.

Neuro Oncol. 2019 Oct 22. pii: noz204. doi: 10.1093/neuonc/noz204. [Epub ahead of print]

PMID:
31634400
4.

To each his own: a personalized vaccine for metastatic melanoma.

Chiocchetti A, Cappellano G, Dianzani U.

Gland Surg. 2019 Aug;8(4):329-333. doi: 10.21037/gs.2017.11.03. No abstract available.

5.

Vitamin D and ω-3 Supplementations in Mediterranean Diet During the 1st Year of Overt Type 1 Diabetes: A Cohort Study.

Cadario F, Pozzi E, Rizzollo S, Stracuzzi M, Beux S, Giorgis A, Carrera D, Fullin F, Riso S, Rizzo AM, Montorfano G, Bagnati M, Dianzani U, Caimmi P, Bona G, Ricordi C.

Nutrients. 2019 Sep 9;11(9). pii: E2158. doi: 10.3390/nu11092158.

6.

Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.

Clemente N, Argenziano M, Gigliotti CL, Ferrara B, Boggio E, Chiocchetti A, Caldera F, Trotta F, Benetti E, Annaratone L, Ribero S, Pizzimenti S, Barrera G, Dianzani U, Cavalli R, Dianzani C.

Front Pharmacol. 2019 Jul 12;10:776. doi: 10.3389/fphar.2019.00776. eCollection 2019.

7.

Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage.

Abate MG, Moretto L, Licari I, Esposito T, Capuano L, Olivieri C, Benech A, Brucoli M, Avanzi GC, Cammarota G, Dianzani U, Clemente N, Panzarasa G, Citerio G, Carfagna F, Cappellano G, Della Corte F, Vaschetto R.

Cells. 2019 Jul 10;8(7). pii: E695. doi: 10.3390/cells8070695.

8.

ICOS deficiency hampers the homeostasis, development and function of NK cells.

Montes-Casado M, Ojeda G, Aragoneses-Fenoll L, López D, de Andrés B, Gaspar ML, Dianzani U, Rojo JM, Portolés P.

PLoS One. 2019 Jul 8;14(7):e0219449. doi: 10.1371/journal.pone.0219449. eCollection 2019.

9.

Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo.

Clemente N, Miletto I, Gianotti E, Invernizzi M, Marchese L, Dianzani U, Renò F.

J Photochem Photobiol B. 2019 Aug;197:111533. doi: 10.1016/j.jphotobiol.2019.111533. Epub 2019 Jun 13.

PMID:
31254952
10.

K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up.

Crespi I, Vecchio D, Serino R, Saliva E, Virgilio E, Sulas MG, Bellomo G, Dianzani U, Cantello R, Comi C.

J Clin Med. 2019 Apr 2;8(4). pii: E446. doi: 10.3390/jcm8040446.

11.

Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis.

Dianzani C, Vecchio D, Clemente N, Chiocchetti A, Martinelli Boneschi F, Galimberti D, Dianzani U, Comi C, Mishto M, Liepe J.

Cells. 2019 Mar 20;8(3). pii: E262. doi: 10.3390/cells8030262.

12.

Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease.

Cappellano G, Comi C, Chiocchetti A, Dianzani U.

Int J Mol Sci. 2019 Jan 8;20(1). pii: E204. doi: 10.3390/ijms20010204. Review.

13.

Glutathione/pH-responsive nanosponges enhance strigolactone delivery to prostate cancer cells.

Argenziano M, Lombardi C, Ferrara B, Trotta F, Caldera F, Blangetti M, Koltai H, Kapulnik Y, Yarden R, Gigliotti L, Dianzani U, Dianzani C, Prandi C, Cavalli R.

Oncotarget. 2018 Nov 9;9(88):35813-35829. doi: 10.18632/oncotarget.26287. eCollection 2018 Nov 9.

14.

Homocysteine and Folate in Inflammatory Bowel Disease: Can Reducing Sulfur Reduce Suffering?

Chiocchetti A, Prodam F, Dianzani U.

Dig Dis Sci. 2018 Dec;63(12):3161-3163. doi: 10.1007/s10620-018-5274-2. No abstract available.

PMID:
30191498
15.

T-Cell-Specific Loss of the PI-3-Kinase p110α Catalytic Subunit Results in Enhanced Cytokine Production and Antitumor Response.

Aragoneses-Fenoll L, Ojeda G, Montes-Casado M, Acosta-Ampudia Y, Dianzani U, Portolés P, Rojo JM.

Front Immunol. 2018 Feb 27;9:332. doi: 10.3389/fimmu.2018.00332. eCollection 2018.

16.

Development and Characterization of Solid Lipid Nanoparticles Loaded with a Highly Active Doxorubicin Derivative.

Stella B, Peira E, Dianzani C, Gallarate M, Battaglia L, Gigliotti CL, Boggio E, Dianzani U, Dosio F.

Nanomaterials (Basel). 2018 Feb 16;8(2). pii: E110. doi: 10.3390/nano8020110.

17.

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.

Clemente N, Ferrara B, Gigliotti CL, Boggio E, Capucchio MT, Biasibetti E, Schiffer D, Mellai M, Annovazzi L, Cangemi L, Muntoni E, Miglio G, Dianzani U, Battaglia L, Dianzani C.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E255. doi: 10.3390/ijms19020255.

18.

Binding of NUFIP2 to Roquin promotes recognition and regulation of ICOS mRNA.

Rehage N, Davydova E, Conrad C, Behrens G, Maiser A, Stehklein JE, Brenner S, Klein J, Jeridi A, Hoffmann A, Lee E, Dianzani U, Willemsen R, Feederle R, Reiche K, Hackermüller J, Leonhardt H, Sharma S, Niessing D, Heissmeyer V.

Nat Commun. 2018 Jan 19;9(1):299. doi: 10.1038/s41467-017-02582-1.

19.

A double blind randomized experimental study on the use of IgM-enriched polyclonal immunoglobulins in an animal model of pneumonia developing shock.

Vaschetto R, Clemente N, Pagni A, Esposito T, Longhini F, Mercalli F, Boggio E, Boldorini R, Chiocchetti A, Dianzani U, Navalesi P.

Immunobiology. 2017 Dec;222(12):1074-1080. doi: 10.1016/j.imbio.2017.09.002. Epub 2017 Sep 8.

PMID:
28911957
20.

Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Castello LM, Raineri D, Salmi L, Clemente N, Vaschetto R, Quaglia M, Garzaro M, Gentilli S, Navalesi P, Cantaluppi V, Dianzani U, Aspesi A, Chiocchetti A.

Mediators Inflamm. 2017;2017:4049098. doi: 10.1155/2017/4049098. Epub 2017 Jul 9. Review.

Supplemental Content

Loading ...
Support Center